FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, in particular to immunomodulatory composition for treating a condition characterized by hypersensitivity to Ara h 1 and/or Ara h 2. Also disclosed is a method of treating or preventing, using said composition, and using said composition for preparing a drug.
EFFECT: invention has the ability effectively treat a condition characterized by hypersensitivity to Ara h 1 and/or Ara h 2.
26 cl, 15 dwg, 25 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
NEW IMMUNOTHERAPEUTIC MOLECULAS AND APPLICATIONS THEREOF | 2013 |
|
RU2687164C2 |
MILK MIXTURE WITH SPECIFIC PEPTIDES OF BETA-LACTOGLOBULIN | 2019 |
|
RU2780747C2 |
IMMUNE MODULATION | 2014 |
|
RU2709771C2 |
IMMUNE MODULATION | 2014 |
|
RU2662927C2 |
HYBRID PEPTIDE CARRYING PROTEINS AS VACCINES AGAINST ALLERGY | 2012 |
|
RU2630652C2 |
RA ANTIGEN PEPTIDES | 2004 |
|
RU2359974C2 |
MODIFIED EPITOPES FOR AMPLIFYING RESPONSES OF CD4+ T-CELLS | 2013 |
|
RU2724994C2 |
EPITOPIC PEPTIDES RAB6KIFL/KIF20A AND VACCINES CONTAINING THEM | 2009 |
|
RU2532105C2 |
MUTANT POLYMERASES OF HEPATITIS B VIRUS | 2012 |
|
RU2625021C2 |
MYBL2 EPITOPE PEPTIDES AND VACCINES CONTAINING THEM | 2009 |
|
RU2496787C2 |
Authors
Dates
2019-05-28—Published
2014-09-25—Filed